Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Letrozole 2.5mg/5ml oral suspension
0803041L0AAABAB
|
Letrozole | Letrozole | Malignant Disease and Immunosuppression | 3 |
|
Nintedanib 100mg capsules
0801050BTAAAAAA
|
Nintedanib | Nintedanib | Malignant Disease and Immunosuppression | 3 |
|
Pegasys 135micrograms/0.5ml inj pre-filled syringes
0802040A0BDABAG
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | 3 |
|
Procarbazine 50mg capsules
0801050U0AAAAAA
|
Procarbazine hydrochloride | Procarbazine hydrochloride | Malignant Disease and Immunosuppression | 3 |
|
Prostap PD DCS 1.88mg inj pre-filled syringes
0803042N0BBAEAG
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 3 |
|
Sandimmun 100mg/ml oral solution
0802020G0BBAAAG
|
Sandimmun | Ciclosporin | Malignant Disease and Immunosuppression | 3 |
|
Siponimod 250microgram tablets
0802040BBAAAAAA
|
Siponimod | Siponimod | Malignant Disease and Immunosuppression | 3 |
|
Suprefact 100micrograms/dose nasal spray
0803042B0BBABAB
|
Suprefact | Buserelin | Malignant Disease and Immunosuppression | 3 |
|
Abiraterone 500mg tablets
0803042T0AAABAB
|
Abiraterone | Abiraterone | Malignant Disease and Immunosuppression | 2 |
|
Anastrozole 1mg/5ml oral solution
0803041B0AAABAB
|
Anastrozole | Anastrozole | Malignant Disease and Immunosuppression | 2 |
|
Apalutamide 60mg tablets
0803042V0AAAAAA
|
Apalutamide | Apalutamide | Malignant Disease and Immunosuppression | 2 |
|
Azathioprine 30mg/5ml oral liquid
0802010G0AABCBC
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 2 |
|
Azathioprine 75mg/5ml oral liquid
0802010G0AAATAT
|
Azathioprine | Azathioprine | Malignant Disease and Immunosuppression | 2 |
|
Calcium folinate 15mg/5ml oral liquid
0801000I0AAAWAW
|
Calcium folinate (Antimetabolite) | Calcium folinate | Malignant Disease and Immunosuppression | 2 |
|
Glatiramer acetate 20mg/1ml inj pre-filled syringes
0802040U0AAABAB
|
Glatiramer acetate | Glatiramer acetate | Malignant Disease and Immunosuppression | 2 |
|
Imatinib 400mg capsules
0801050AAAAADAD
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 2 |
|
Imatinib 400mg tablets
0801050AAAAABAB
|
Imatinib mesilate | Imatinib mesilate | Malignant Disease and Immunosuppression | 2 |
|
Megestrol 160mg/5ml oral suspension
0803020L0AAACAC
|
Megestrol acetate | Megestrol acetate | Malignant Disease and Immunosuppression | 2 |
|
Melphalan 2mg tablets
0801010S0AAABAB
|
Melphalan | Melphalan | Malignant Disease and Immunosuppression | 2 |
|
Mesna 400mg tablets
0801000T0AAACAC
|
Mesna (Cancer) | Mesna | Malignant Disease and Immunosuppression | 2 |
|
Methotrexate 5mg/2ml solution for injection vials
0801030P0AAAIAI
|
Methotrexate | Methotrexate | Malignant Disease and Immunosuppression | 2 |
|
Mitotane 500mg tablets
0801050R0AAAAAA
|
Mitotane | Mitotane | Malignant Disease and Immunosuppression | 2 |
|
Pegasys 90micrograms/0.5ml inj pre-filled syringes
0802040A0BDAEAP
|
Pegasys | Peginterferon alpha | Malignant Disease and Immunosuppression | 2 |
|
Prostap SR 3.75mg inj vials
0803042N0BBAAAA
|
Prostap | Leuprorelin acetate | Malignant Disease and Immunosuppression | 2 |
|
Puri-Nethol 50mg tablets
0801030L0BBAAAA
|
Puri-Nethol | Mercaptopurine | Malignant Disease and Immunosuppression | 2 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.